Delivery Order SPE2DB22D2009-SPE2DB24FM1KD

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has a ceiling value of $2,388.66 and a completion date of May 25, 2023. It is a firm fixed-price contract classified as a delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This contract is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Spiriva Respimat 1.25 MCG inhalation medication with a ceiling value of $2,880.80. The contract is a firm-fixed price delivery order with an ultimate completion date of September 24, 2024. This contract is not set aside for any special business category. AmerisourceBergen is a major supplier of pharmaceutical products and...
This contract represents a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.56, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4 gram quantity. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,095,220 units of Spiriva Respimat 1.25 mcg inhalation medication. The contract has a firm fixed price of $2,460.29 and a completion date of June 1, 2023. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,602.25, is for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution. The contract has a ceiling value of $2,616.80 and runs through September 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this as a firm-fixed-price contract. The company has also been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Spiriva Respimat 2.5 mcg Inhalation Aerosol in 4 gram units. The contract has an ultimate completion date of January 4, 2024, and a ceiling value of $2,340.45. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, valued at $5,560.32, is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 19, 2024. AmerisourceBergen, through its Corporate Office Division, will supply this respiratory medication to support government healthcare programs. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The $2,458.64 firm-fixed-price contract has a completion date of March 9, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,736,111 units of Spiriva Respimat 1.25 mcg inhalational medication, with a ceiling value of $3,271.00. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM1KD
    Delivery Order

This is a delivery order (DO) contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication with a ceiling value of $2,840.24. The contract is a firm fixed-price arrangement with a performance period through August 2024. There is no set-aside designation for this award. As a major supplier to the federal government, AmerisourceBergen leverages its extensive pharmaceutical distribution network to provide a wide range of critical medical products, including specialty medications, vaccines, and medical supplies, to support various military treatment facilities and government healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, to efficiently deliver these essential medical commodities.

Generated 11/12/24, 9:06 AM